BR0313546A - Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade - Google Patents
Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idadeInfo
- Publication number
- BR0313546A BR0313546A BR0313546-2A BR0313546A BR0313546A BR 0313546 A BR0313546 A BR 0313546A BR 0313546 A BR0313546 A BR 0313546A BR 0313546 A BR0313546 A BR 0313546A
- Authority
- BR
- Brazil
- Prior art keywords
- patients
- age
- macular degeneration
- visual acuity
- related macular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Abstract
"USO DE ACETATO DE ANACORTAVE PARA A PROTEçãO DE ACUIDADE VISUAL EM PACIENTES COM DEGENERAçãO MACULAR RELACIONADA COM A IDADE". A presente invenção refere-se ao uso do acetato de anacortave ou do álcool do mesmo para a proteção da acuidade visual em pacientes com degeneração macular devida a idade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40122002P | 2002-08-05 | 2002-08-05 | |
PCT/US2003/020154 WO2004012742A1 (en) | 2002-08-05 | 2003-06-26 | Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0313546A true BR0313546A (pt) | 2005-07-12 |
Family
ID=31495940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0313546-2A BR0313546A (pt) | 2002-08-05 | 2003-06-26 | Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade |
Country Status (17)
Country | Link |
---|---|
US (2) | US20060166956A1 (pt) |
EP (1) | EP1539182A4 (pt) |
JP (1) | JP2005535691A (pt) |
KR (1) | KR20050026510A (pt) |
CN (1) | CN1674913A (pt) |
AR (1) | AR040599A1 (pt) |
AU (1) | AU2003281817A1 (pt) |
BR (1) | BR0313546A (pt) |
CA (1) | CA2494211A1 (pt) |
DE (1) | DE03742226T1 (pt) |
ES (1) | ES2244361T1 (pt) |
MX (1) | MXPA05000773A (pt) |
PL (1) | PL375024A1 (pt) |
RU (1) | RU2322239C2 (pt) |
TW (1) | TW200410699A (pt) |
WO (1) | WO2004012742A1 (pt) |
ZA (1) | ZA200500731B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060166956A1 (en) * | 2002-08-05 | 2006-07-27 | Jerdan Janice A | Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
ZA200505990B (en) * | 2003-02-20 | 2006-12-27 | Alcon Inc | Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
US20070059381A1 (en) * | 2003-06-20 | 2007-03-15 | Barker Ronnie C | Treatment of amd with combination of ingredients |
JP2007506678A (ja) * | 2003-09-23 | 2007-03-22 | アルコン,インコーポレイテッド | 注入のためのトリアムシノロンアセトアニドおよび酢酸アネコルタブの処方物 |
US7257366B2 (en) * | 2003-11-26 | 2007-08-14 | Osmosis Llc | System and method for teaching a new language |
WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
US20060182783A1 (en) * | 2004-04-30 | 2006-08-17 | Allergan, Inc. | Sustained release intraocular drug delivery systems |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US7261529B2 (en) * | 2005-09-07 | 2007-08-28 | Southwest Research Institute | Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
US7758778B2 (en) * | 2005-09-07 | 2010-07-20 | Southwest Research Institute | Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents |
US9693967B2 (en) * | 2005-09-07 | 2017-07-04 | Southwest Research Institute | Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates |
WO2007047626A1 (en) * | 2005-10-14 | 2007-04-26 | Alcon, Inc. | Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis |
ZA200903649B (en) * | 2006-12-18 | 2010-08-25 | Alcon Res Ltd | Devices and methods for ophthalmic drug delivery |
CN101759741B (zh) * | 2008-11-06 | 2013-01-09 | 天津金耀集团有限公司 | 一种化合物及其在制备治疗血管新生的药物中的应用 |
CN101923856B (zh) | 2009-06-12 | 2012-06-06 | 华为技术有限公司 | 语音识别训练处理、控制方法及装置 |
EP2817031A4 (en) * | 2012-02-22 | 2015-08-05 | Tufts College | COMPOSITIONS AND METHODS FOR OCULAR DELIVERY OF A THERAPEUTIC AGENT |
RU2489146C1 (ru) * | 2012-07-11 | 2013-08-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт глазных болезней" Российской академии медицинских наук (ФГБУ "НИИГБ" РАМН) | Способ лечения "сухой" формы возрастной макулярной дегенерации |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876250A (en) * | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
US5371078A (en) * | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
US5770592A (en) * | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
US5679666A (en) * | 1991-11-22 | 1997-10-21 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
ES2231257T3 (es) * | 1999-10-21 | 2005-05-16 | Alcon Inc. | Dispositivo para la administracion de farmacos. |
US20060166956A1 (en) * | 2002-08-05 | 2006-07-27 | Jerdan Janice A | Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
WO2007047626A1 (en) * | 2005-10-14 | 2007-04-26 | Alcon, Inc. | Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis |
-
2003
- 2003-06-26 US US10/521,707 patent/US20060166956A1/en not_active Abandoned
- 2003-06-26 JP JP2004526013A patent/JP2005535691A/ja active Pending
- 2003-06-26 CN CNA038188260A patent/CN1674913A/zh active Pending
- 2003-06-26 EP EP03742226A patent/EP1539182A4/en not_active Withdrawn
- 2003-06-26 DE DE03742226T patent/DE03742226T1/de active Pending
- 2003-06-26 PL PL03375024A patent/PL375024A1/xx unknown
- 2003-06-26 WO PCT/US2003/020154 patent/WO2004012742A1/en not_active Application Discontinuation
- 2003-06-26 CA CA002494211A patent/CA2494211A1/en not_active Abandoned
- 2003-06-26 KR KR1020057001248A patent/KR20050026510A/ko not_active Application Discontinuation
- 2003-06-26 US US10/606,501 patent/US20040127472A1/en not_active Abandoned
- 2003-06-26 RU RU2005106234/14A patent/RU2322239C2/ru not_active IP Right Cessation
- 2003-06-26 ES ES03742226T patent/ES2244361T1/es active Pending
- 2003-06-26 AU AU2003281817A patent/AU2003281817A1/en not_active Abandoned
- 2003-06-26 MX MXPA05000773A patent/MXPA05000773A/es not_active Application Discontinuation
- 2003-06-26 BR BR0313546-2A patent/BR0313546A/pt not_active IP Right Cessation
- 2003-07-07 TW TW092118474A patent/TW200410699A/zh unknown
- 2003-07-17 AR AR20030102575A patent/AR040599A1/es unknown
-
2005
- 2005-01-25 ZA ZA200500731A patent/ZA200500731B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PL375024A1 (en) | 2005-11-14 |
JP2005535691A (ja) | 2005-11-24 |
RU2005106234A (ru) | 2005-08-10 |
AR040599A1 (es) | 2005-04-13 |
US20040127472A1 (en) | 2004-07-01 |
DE03742226T1 (de) | 2006-03-09 |
MXPA05000773A (es) | 2005-04-19 |
CA2494211A1 (en) | 2004-02-12 |
KR20050026510A (ko) | 2005-03-15 |
TW200410699A (en) | 2004-07-01 |
WO2004012742A1 (en) | 2004-02-12 |
AU2003281817A1 (en) | 2004-02-23 |
CN1674913A (zh) | 2005-09-28 |
EP1539182A1 (en) | 2005-06-15 |
US20060166956A1 (en) | 2006-07-27 |
ES2244361T1 (es) | 2005-12-16 |
RU2322239C2 (ru) | 2008-04-20 |
EP1539182A4 (en) | 2010-01-20 |
ZA200500731B (en) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0313546A (pt) | Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade | |
WO2006035237A3 (en) | Methods and compositions relating to alzheimer's disease | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
WO2008006535A3 (en) | Use of a cationic colloidal preparation for the diagnosis and treatment of ocular diseases | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA04004842A (es) | Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1. | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
DE602004017252D1 (de) | Körperlichepflegemittel Zusammensetzungen enthaltend strukturierte Pflegemittel-Vormischung | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
PT1594833E (pt) | Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
EP1596877A4 (en) | PREPARATION FOR PREVENTING AND TREATING DISEASES AND CONDITIONS INDUCED BY CARBOHYDRATES | |
WO2004096216A3 (en) | Use of a topical medicament comprising riluzole | |
BRPI0516666A (pt) | 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização | |
BRPI0414699A (pt) | formulações de acetato de anecortave e acetonida de triancinolona para injeção | |
BRPI0520258A2 (pt) | uso de uma composição farmacêutica, método para preparar uma composição farmacêutica, e, uso de uma quantidade eficaz de acetato de eslicarbazepina | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BR0308713A (pt) | Co-esférula de dha e alecrim, e métodos de uso | |
WO2000021528A8 (en) | Use of ophthalmic composition comprising vitamin a and vitamin e | |
WO2007109093A3 (en) | Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof | |
WO2007017146A3 (en) | Use of collismycin and derivatives thereof as oxidative stress inhibitors | |
AU2003273843A1 (en) | Use of skin-protecting substances | |
WO2003015780A8 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
BRPI0407742A (pt) | uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida | |
CA2436511A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8AANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |